Since March 2020, when doctors first used IVM against COVID-19, more than 20 randomized clinical trials (RCTs) have confirmed its miraculous efficacy against COVID for both inpatient and outpatient treatment. Six of seven meta-analyses of IVM treatment RCTs completed in 2021 found notable reductions in COVID-19 mortality. The relevant studies “all showed significant benefit for high-risk outpatients,” says the eminent Yale epidemiologist Dr. Harvey Risch. The only studies where its performance was anything short of stellar were those that investigated its efficacy in patients in very late
...more
Ivermectin was found to be highly effective vs Covid with top-class studies.
